Todd Stottlemyer



Todd Stottlemyer serves as CEO of CNSI, a private equity backed (A&M Capital) healthcare technology solutions company.

Prior to joining CNSI, Todd served as CEO of the Inova Health System’s Center for Personalized Health; as CEO of Acentia, a private equity backed (Snow Phipps Group) information technology company (sold to MAXIMUS); as President and CEO of the National Federation of Independent Business; as CEO of Apogen Technologies, a private equity backed (Arlington Capital Partners) information technology company (sold to QinetiQ); as President of McGuireWoods Consulting; as Chief Financial Officer of BTG, a publicly-traded information technology company; and as Corporate Vice President of BDM International, a two times publicly traded and private equity backed (The Carlyle Group) information technology company (sold to TRW; now Northrop Grumman).

Todd currently serves as a Venture Partner for Blue Delta Capital Partners and on the boards of LMI, IST Research, and Verato.

Todd attended William & Mary, graduating Phi Beta Kappa with a B.A, and he received a Juris Doctor degree from the Georgetown University Law Center.